New Post

CVS Study Finds Smoking Cessation Programs with Financial Incentives Increase Rates of Quitting and Staying Smoke-free

WOONSOCKET, R.I.,– A new study by the CVS Health (NYSE: CVS) Research Institute and researchers at the Perelman School of Medicine at the University of Pennsylvania, published today in the New England Journal of Medicine, finds that employer-sponsored smoking cessation programs with financial incentives are associated with higher rates of quitting smoking and sustained abstinence. […]

Read More

Takeda Agrees to Settle ACTOS Product Liability Lawsuits and Claims; Takeda Stresses Continued Commitment to ACTOS

Deerfield, Ill., U.S., and Osaka, Japan, April 29, 2015 – Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that they have reached an agreement expected to resolve the vast majority of ACTOS (pioglitazone HCl) product liability lawsuits pending against Takeda in the U.S. Takeda will take a $2.7 billion […]

Read More

IBM to Acquire Phytel to Help Healthcare Providers Deliver Higher Value Care

Armonk, NY and Dallas, Texas: IBM (NYSE: IBM) today announced plans to acquire Phytel, a leading provider of integrated population health management software. The acquisition once completed will bolster the company’s efforts to apply advanced analytics and cognitive computing to help primary care providers, large hospital systems and physician networks improve healthcare quality and effect […]

Read More

Apple Announces ResearchKit Available Today to Medical Researchers

CUPERTINO, California— Apple® today announced ResearchKit™, a software framework designed for medical and health research that helps doctors, scientists and other researchers gather data more frequently and more accurately from participants using mobile devices, is now available to researchers and developers. The first research apps developed using ResearchKit study asthma, breast cancer, cardiovascular disease, diabetes […]

Read More

Hybrid OR: Maquet and GE Healthcare announce cooperation in the field of the Hybrid OR

Rastatt, April 2015. Maquet and GE Healthcare are announcing they are developing together a new flexible angiography Hybrid OR solution[1]. The combined system for surgical procedures and catheter-based interventions will consist of the angiography system Discovery IGS 730 (GE) and the Magnus operating table system (Maquet). Both companies will be presenting their integrated solution for […]

Read More

Drug Firm Mylan Proposes To Acquire Perrigo For $205 Per Share

POTTERS BAR, England, April 8, 2015 — Mylan N.V. (NASDAQ: MYL) today announced that Mylan has made a proposal to acquire Perrigo Company plc (NYSE: PRGO) in a cash-and-stock transaction that would create a diversified, global pharmaceutical leader with an unmatched commercial and operating platform and a unique, one-of-a-kind profile. The combination of these highly […]

Read More

GE Healthcare Strengthens “Make In India” Capability For Accessible, Affordable Healthcare

BANGALORE, INDIA, GE Healthcare, a unit of General Electric Company (NYSE: GE), reiterated its commitment towards ‘Make in India’ by strengthening its R&D, Manufacturing, Supply Chain, Distribution capabilities and Education initiative. With enhanced capabilities, GE today announced the launch of Revolution™ ACTs*, first Computed Tomography system designed and developed by GE Healthcare in India. The […]

Read More

GE Healthcare Announces Omnyx Agreement with Argent Global Services to transform Digital Pathology

PITTSBURGH, PA, — Omnyx, LLC, the digital pathology joint venture between University of Pittsburgh Medical Center (UPMC) and GE Healthcare, today announced a memorandum of understanding with Argent Global Services, a process engineering and management consulting firm, to help revolutionize the pathology laboratory. The agreement is intended to provide hospitals and academic research facilities with […]

Read More

US$10 Million Investment into the Registration of Moxidectin, an Important New Global Health Medicine for River Blindness

LONDON – UK: The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (Medicines Development) announced today a 10 million USD program for the registration of moxidectin for the treatment of river blindness (onchocerciasis). River blindness is a debilitating neglected tropical disease caused by the worm Onchocerca volvulus, which is transmitted through the […]

Read More

New Apps to Aid Research on Asthma, Breast Cancer, Cardiovascular Disease, Diabetes & Parkinson’s Disease

SAN FRANCISCO — Apple® today announced ResearchKit™, an open source software framework designed for medical and health research, helping doctors and scientists gather data more frequently and more accurately from participants using iPhone® apps. World-class research institutions have already developed apps with ResearchKit for studies on asthma, breast cancer, cardiovascular disease, diabetes and Parkinson’s disease.* […]

Read More